✦ LIBER ✦

Increases of pentraxin 3 plasma levels in patients with Parkinson's disease

✍ Scribed by Ho-Won Lee; Jihye Choi; Kyoungho Suk

Book ID: 111701040
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 258 KB
Volume: 26
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.23871

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolcapone increases plasma catecholamine

Tolcapone increases plasma catecholamine levels in patients with Parkinson's disease

✍ A. Rojo; A. Fontán; M.A. Mena; A. Herranz; S. Casado; J.G. de Yébenes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Plasma levels of nitrates in patients wi

Plasma levels of nitrates in patients with Parkinson's disease

✍ JoséAntonio Molina; Félix Javier Jiménez-Jiménez; JoséAntonio Navarro; Eduardo R 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Plasma levels of inorganic sulfates in p

Plasma levels of inorganic sulfates in patients with Parkinson's disease

✍ F. J. Jimenéz-Jiménez; J. A. Molina; M. V. Aguilar; A. Jorge-Santamaria; C. J. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Abstract: 1071 PLASMA PENTRAXIN 3 LEVELS

Abstract: 1071 PLASMA PENTRAXIN 3 LEVELS REFLECT METABOLIC SYNDROME IN PATIENTS WITH CORONARY ARTERY DISEASE

✍ Miyazaki, T; Chiuve, S; Sacks, F; Ridker, P; Libby, P; Sagara, M; Aikawa, M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Chronic levodopa intake increases levodo

Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease

✍ Siegfried Muhlack; Dirk Woitalla; Jacob Welnic; Svenja Twiehaus; Horst Przuntek; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Increased levels of serum pentraxin 3, a

Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease

✍ Ivana Hollan; Barbara Bottazzi; Ivan Cuccovillo; Øystein T. Førre; Knut Mikkelse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 143 KB 👁 2 views

## Abstract ## Objective Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy c